Diagnostic power and clinical impact of exome sequencing in a cohort of 500 patients with rare diseasesCaio Robledo D’Angioli Costa Quaio, Wagner Antonio da Rosa Baratela, Maria Carolina Tostes Pintão et al.|American Journal of Medical Genetics Part C Seminars in Medical Genetics|2020Cited by 39
CALR mutations screening in wild type JAK2V617F and MPLW515K/L Brazilian myeloproliferative neoplasm patientsDaniela Prudente Teixeira Nunes, Elvira Maria Guerra‐Shinohara, Luciene Terezina de Lima et al.|Blood Cells Molecules and Diseases|2015Cited by 19
Mutational Profiling of Acute Myeloid Leukemia with Normal Cytogenetics in Brazilian Patients: The Value of Next-Generation Sequencing for Genomic ClassificationThiago Rodrigo de Noronha, Maria de Lourdes Chauffaille, Miguel Mitne‐Neto|Journal of Investigative Medicine|2017Cited by 15
JAK2-mutated acute myeloid leukemia: comparison of next-generation sequencing (NGS) and single nucleotide polymorphism array (SNPa) findings between two casesThiago Rodrigo de Noronha, Maria de Lourdes Chauffaille, Miguel Mitne‐Neto|Autopsy and Case Reports|2019Cited by 9
Molecular genetic tests for <i>JAK2</i> V617F, Exon12_ <i>JAK2</i> and <i>MPL</i> W515K/L are highly informative in the evaluation of patients suspected to have BCR-ABL1-negative myeloproliferative neoplasmsMarcos Tadeu dos Santos, Edgar Gil Rizzatti, Miguel Mitne‐Neto et al.|Journal of Clinical Pathology|2013Cited by 7